曾艳, 王劲, 刘瑜, 彭翠翠, 金婕, 周旭, 曾东风. 180例黏膜相关淋巴瘤患者的临床特征和预后分析[J]. 中国肿瘤临床, 2020, 47(9): 433-437. DOI: 10.3969/j.issn.1000-8179.2020.09.402
引用本文: 曾艳, 王劲, 刘瑜, 彭翠翠, 金婕, 周旭, 曾东风. 180例黏膜相关淋巴瘤患者的临床特征和预后分析[J]. 中国肿瘤临床, 2020, 47(9): 433-437. DOI: 10.3969/j.issn.1000-8179.2020.09.402
Yan Zeng, Wang Jin, Liu Yu, Peng Cuicui, Jin Jie, Zhou Xu, Zeng Dongfeng. Analysis of clinical and prognostic features in 180 patients with mucosa associated lymphoma tissue lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(9): 433-437. DOI: 10.3969/j.issn.1000-8179.2020.09.402
Citation: Yan Zeng, Wang Jin, Liu Yu, Peng Cuicui, Jin Jie, Zhou Xu, Zeng Dongfeng. Analysis of clinical and prognostic features in 180 patients with mucosa associated lymphoma tissue lymphoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 47(9): 433-437. DOI: 10.3969/j.issn.1000-8179.2020.09.402

180例黏膜相关淋巴瘤患者的临床特征和预后分析

Analysis of clinical and prognostic features in 180 patients with mucosa associated lymphoma tissue lymphoma

  • 摘要:
      目的   对黏膜相关淋巴组织(mucosa associated lymphoid tissue,MALT)进行较大样本的单中心回顾性分析,获取其临床特征及生存相关影响因素数据。
      方法   回顾性分析2012年9月至2019年5月陆军军医大学大坪医院经病理活检确诊的180例MALT淋巴瘤患者。
      结果   全组180例患者,其中男性99例(55.0%),女性81例(45.0%),发病年龄31~84岁,中位年龄57岁。原发部位为胃肠59例(32.8%),眼66例(36.7%),其他结外原发部位包括肺、咽淋巴环、甲状腺、腮腺和睾丸等,共55例(30.6%)。临床分期Ⅰ~Ⅱ期173例(96.1%),Ⅲ~Ⅳ期7例(3.9%)。胃肠组、眼部组和其他组5年生存率(overall survival,OS)分别为96.7%、95.5%和86.4%,差异无统计学意义(P=0.118);5年无进展生存率(progression-free survival,PFS)分别为82.4%、86.6%和86.4%,差异无统计学意义(P=0.862)。预后单因素相关分析提示,低血红蛋白水平(P=0.006)、β2-微球蛋白(β2-MG)升高(P=0.013)为影响患者OS的相关因素;β2-MG升高(P=0.004)为影响患者OS及PFS的相关因素。多因素分析表明低血红蛋白水平与生存期有关(P=0.015)。
      Conclusions:   MALT淋巴瘤可起源于全身不同部位,其临床过程进展缓慢,复发晚,OS较长。低血红蛋白水平、β2-MG可作为MALT淋巴瘤重要的临床预后指标。

     

    Abstract:
      Objective:   A single-center retrospective analysis was performed to obtain data on the clinical characteristics and the factors influencing the survival of patients with mucosa associated lymphoma tissue lymphoma (MALT lymphoma).
      Method:   From September 2012 to May 2019, we retrospectively analyzed 180 cases of MALT lymphoma diagnosed through pathological biopsy.
      Result:   Among the 180 patients, 99 (55.0%) were male and 81 (45.0%) were female. The age at onset was 31-84 years, and the median age was 57 years. There were 59 (32.8%), 66 (96.1%), and 55 (3.9%) cases involving gastrointestinal, ocular, and other extranodal primary sites, which included the lung, pharyngeal lymph ring, thyroid, parotid gland, and testis, respectively. Moreover, there were 173 (94.4%) cases of clinical stage Ⅰ-Ⅱdisease and 7 cases (5.6%) of clinical stage Ⅲ-Ⅳ disease. The 5-year overall survival (OS) rates in the gastrointestinal, ocular, and other groups were 96.7%, 95.5%, and 86.4%, respectively, and the difference was not statistically significant (P=0.118). The 5-year progression-free survival (PFS) rates were 82.4%, 86.6%, and 86.4% in the corresponding groups, respectively, and the difference was not statistically significant (P=0.862). The single-factor correlation analysis of prognosis indicated that low hemoglobin (P=0.006) and high β2-microglobulin (P=0.013) levels were related to OS, while an increase in β2-microglobulin (β2-MG) (P=0.004) levels was related to OS and PFS. Survival analysis showed that a low hemoglobin level was significantly associated with OS (P=0.015).
      Conclusions:   MALT lymphoma can originate from different parts of the body. Additionally, the patients show slow clinical progress, late recurrence, and long total survival. Low hemoglobin and β2-MG levels can be used as important indexes for clinical prognosis.

     

/

返回文章
返回